Find, organize, attend, and make the most of Oncology & Hematology events worldwide

EHA ReCon 2026
Conference

EHA ReCon 2026

EHA is proud to announce the fou‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.rth edition of the EHA Research Conference, titled ‘From cradle to grave: normal and malignant hematopoiesis in young and aged settings.’ ‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.

Hemato-Oncology

Date & time

Start March 22, 2026
End March 25, 2026

Location

City Espoo
Country Finland
Venue DIPOLI – Aalto University
Event format In-person

People & organizations

Organizer(s) European Hematology Association (EHA)